Berkshire Asset Management LLC Eli Lilly & CO Transaction History

Berkshire Asset Management LLC

$2.09 Billion
Q3 2024

A detailed history of Berkshire Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Berkshire Asset Management LLC holds 3,886 shares of LLY stock, worth $3.09 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,886

Previous 3,886 -0.0%

Holding current value

$3.09 Million

Previous $3.52 Million 2.16%

% of portfolio

0.16%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $72,487 - $90,904	-100 Reduced 2.51%	3,886 $3.52 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $34,347 - $45,952	-58 Reduced 1.43%	3,986 $3.1 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $3,676 - $4,333	-7 Reduced 0.17%	4,044 $2.36 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $3,477 - $4,794	-8 Reduced 0.2%	4,051 $2.18 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $20,342 - $27,200	58 Added 1.45%	4,059 $1.9 Million
Q1 2023 Jun 06, 2023	BUY	$310.63 - $364.82 $1.24 Million - $1.46 Million	4,001 New	4,001 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $24,904 - $28,381	-84 Reduced 2.17%	3,791 $1.23 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $21,183 - $24,872	76 Added 2.0%	3,875 $1.26 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $15,254 - $18,957	65 Added 1.74%	3,799 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5,846 - $7,255	-26 Reduced 0.69%	3,734 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $79,554 - $97,902	359 Added 10.56%	3,760 $869,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $614,050 - $794,269	3,401 New	3,401 $781,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $604,040 - $781,958	-3,676 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $51,009 - $67,498	391 Added 11.9%	3,676 $621,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $36,833 - $44,328	-270 Reduced 7.59%	3,285 $539,000
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $51,786 - $64,097	-435 Reduced 10.9%	3,555 $493,000
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $813,126 - $1.01 Million	-7,605 Reduced 65.59%	3,990 $524,000
Q3 2019 Oct 07, 2019	BUY	$106.79 - $116.16 $9,611 - $10,454	90 Added 0.78%	11,595 $1.3 Million
Q3 2018 Oct 12, 2018	SELL	$85.86 - $107.31 $387,314 - $484,075	-4,511 Reduced 28.17%	11,505 $1.24 Million
Q2 2018 Jul 17, 2018	BUY	$75.7 - $86.88 $54,201 - $62,206	716 Added 4.68%	16,016 $1.37 Million
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $232,203 - $274,100	3,129 Added 25.71%	15,300 $1.18 Million
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $617,254 - $662,075	7,533 Added 162.42%	12,171 $1.03 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $357,450 - $396,734	4,638	4,638 $397,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Eli Lilly & CO Transaction History